Laxmi Organic Industries shareholders have approved all six resolutions placed before the company’s 37th Annual General Meeting (AGM) held on August 5, 2026. The meeting, conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM), saw the adoption of FY26 financial statements, declaration of final dividends, and re-appointment of two directors. The scrutinizer’s report, issued by M/s. GMJ & Associates on August 7, 2026, confirms that every resolution passed with the requisite majority under the Companies Act, 2013.

The AGM was convened in compliance with Regulation 30 and Part-A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, alongside relevant Ministry of Corporate Affairs (MCA) circulars. Ravi Goenka, Executive Chairman and Whole-time Director, presided over the proceedings, while Aniket Hirpara, Company Secretary and Compliance Officer, conducted the session. A total of 40 members attended, satisfying quorum requirements under Section 103 of the Companies Act, 2013.

Voting Results and Resolution Details

Shareholders voted on ordinary and special resolutions covering financial approvals, dividend declarations, director appointments, and auditor remuneration. The cut-off date for identifying eligible voters was July 29, 2026. Remote e-voting occurred between August 1 and August 4, 2026, facilitated by MUFG Link Intime India Private Limited. Votes were unblocked by the scrutinizer on August 5, 2026, at 12:23 PM in the presence of independent witnesses.

Harshvardhan Goenka (DIN 08239696) and Manish Chokhani (DIN 00204011) retired by rotation and were successfully re-appointed. The promoter group, holding 192,206,496 shares, voted unanimously in favour of all resolutions. Public institutions polled 91.60% of their eligible votes, while public non-institutions polled 2.22%. Notably, for Item No. 6 (Special Resolution), public institutions voted against the resolution with 10.31% opposition, though the overall vote remained overwhelmingly positive due to promoter support.

Scrutiny Process

M/s. GMJ & Associates, represented by Partner Mahesh Soni, acted as the Scrutinizer to ensure a fair and transparent voting process. The scrutinizer reconciled e-voting data from MUFG Intime’s InstaVOTE and Instameet platforms with company records to eliminate duplicate votes. One shareholder holding 5,000 shares abstained from voting on Items 1, 3, 4, 5, and 6, while two shareholders holding 5,115 shares abstained from Item 2. The Statutory Auditors’ report contained no qualifications or adverse remarks.

The final voting results and Scrutinizer’s Report have been submitted to BSE Limited and National Stock Exchange of India Limited. The documents will be made available on the company’s website within two working days of the AGM.

Laxmi Organic Industries Ltd delivered a robust financial performance in the first quarter of FY27, reporting revenue from operations of ₹9,683 million, a 40% year-on-year increase. The Mumbai-based specialty chemicals manufacturer also saw its EBITDA surge by 272% YoY to ₹1,143 million, reflecting strong operational leverage amidst a volatile global macro environment. The results, discussed during an investor conference call on July 30, 2026, highlight the company’s ability to navigate geopolitical disruptions and raw material price spikes through supply chain agility and strategic pricing.

The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Aniket Hirpara, Company Secretary and Compliance Officer of Laxmi Organic Industries Limited, signed the submission to BSE Limited and the National Stock Exchange of India Limited. The company confirmed that no unpublished price-sensitive information was shared during the meeting.

Financial Performance Highlights

Amit Jain, Chief Financial Officer, attributed the revenue growth to a combination of volume expansion (approximately 10%) and higher price realization driven by product mix shifts. Despite challenges from increased freight costs and energy tariffs, procurement efficiencies helped sustain operating profitability. Net working capital increased slightly during the quarter to secure key raw materials in a volatile market, though management expects this to normalize over time.

Segmental Breakdown

The Essentials business led the charge with revenue of ₹7,265 million, growing 50% YoY, supported by double-digit volume growth. Dr. Rajan Venkatesh, Managing Director and CEO, noted that the Essentials segment delivered an EBITDA margin of 11% to 12% in the quarter, a significant improvement from low single-digit margins in previous periods. He emphasized that while Essentials is cyclical, the company’s economies of scale allow it to capitalize on upcycles effectively.

The Specialty business reported revenue of ₹2,418 million, rising 17% YoY. Venkatesh explained that the Specialty segment had faced headwinds in FY26 due to deflationary feedstock pricing and the phase-out of a key product accounting for 10% of revenues. However, Q1FY27 marked a positive rebound, with momentum building in diketene derivatives and other high-value products.

What the Numbers Show

The sharp divergence between revenue growth (40%) and EBITDA growth (272%) underscores the operating leverage Laxmi Organic Industries achieved in Q1FY27. While raw material costs for acetic acid and methanol spiked significantly in March and April, moderating only towards June, the company managed to pass on costs through pricing without losing volume share. This suggests strong customer stickiness and pricing power, particularly in the Essentials segment where margins expanded from low single-digits to over 11%. Additionally, the company maintains a healthy net debt-to-equity ratio of around 0.3x, with term debt peaking at approximately ₹6,100 million as the Dahej capex cycle nears completion.

Strategic Projects and Outlook

Management provided updates on key capital projects. The Dahej Phase 2 project, which integrates ketene and diketene capabilities, is progressing well. Phase 1 was already capitalized, representing 15-18% of total capex, while 85% of Phase 2 capex is expected to be capitalized in Q2FY27. Full-year capex estimates are between ₹125 crore and ₹150 crore. Incremental depreciation of ₹7-7.5 crore per quarter is expected post-capitalization.

The Hitachi joint venture project, 'Project Vaayu,' anticipates mechanical completion in early Q3FY27, with revenue contributions expected in FY28. Venkatesh highlighted that the company remains the leader in electrochemical fluorination in India, with a robust pipeline for new product development leveraging this technology. Looking ahead, management expects continued volatility due to geopolitical tensions in West Asia and logistical disruptions from typhoons in South China, but remains confident in its ability to navigate these challenges through agility and scale.